By 2033, the bioabsorbable stents market sales is projected to be valued at US$ 253.9 million worldwide. Our pharmaceutical specialists believe that suppliers of bioabsorbable stents, with a present valuation of US$ 171.8 million in 2023, can anticipate a CAGR of 4% through 2033.
The bioabsorbable stents market is witnessing notable developments as a result of ongoing advancements in medical technology and a growing focus on enhancing patient outcomes. Bioabsorbable stents, designed to gradually dissolve in the body after providing structural support to the blood vessels, offer a promising alternative to traditional metallic stents. This innovative approach aims to address some of the limitations associated with permanent stents, such as the potential for long-term complications. Bioabsorbable stents are particularly relevant in the field of interventional cardiology, where they can aid in the treatment of coronary artery disease while minimizing the risk of long-term complications and facilitating the natural healing process.
The competitive landscape of the bioabsorbable stents market is marked by ongoing research and development activities, with various medical device companies striving to enhance the design, biocompatibility, and overall performance of these stents. As clinical studies continue to explore the safety and efficacy of bioabsorbable stents, the market is expected to evolve, potentially becoming a standard in certain medical applications. The adoption of bioabsorbable stents reflects a broader trend in the healthcare industry towards personalized and minimally invasive interventions, aiming to improve patient outcomes and quality of life.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-4819
Coronary artery disease (CAD) is the leading cause of death worldwide. Bioabsorbable polymeric stents have grown in popularity due to their ability to treat CAD without causing long-term complications. Bioabsorbable polymeric stents (BMSs) have undergone a sustainable revolution in terms of material processing, mechanical performance, and biodegradability. As per According to the study, end users prefer biodegradable polymers and copolymers as material choices for bioabsorbable stents.
The growth of the global bioabsorbable stents market is influenced by factors such as rise in cardiovascular surgeries on a global scale, lower treatment cost, and exact stent placement. These factors are reinforced with technological developments, which are again intensifying thereby fuelling the growth of the global bioabsorbable stent market. However, there are certain limiting factors which offer challenge to the growth of the global market, such as possibilities of complications during insertion or post-surgery and less awareness about bioabsorbable stents.
The global bioabsorbable stents market is poised to reach a value of around US$ 350 Mn by the end of 2022 and is anticipated to grow at a robust CAGR during the period of forecast of 2017 to 2022.
6 Forecast Highlights on Global Bioabsorbable Stents Market
- By product type, polymeric stents segment is expected to dominate the global market. As of 2017 statistics, this segment reflected a higher market share of 57.6% thus portraying dominance and is expected to continue to dominate the global market throughout the forecast period
- Polymeric-coated metallic stents product segment is anticipated to reflect the highest growth rate to register an exponential CAGR of 12.2% throughout the period of forecast 2017-2022. This segment is also poised to gain the highest BPS by the end of 2022
- Europe region is the most lucrative region and dominates the global market. This region is poised to grow at a significant CAGR during the forecast period. North America region is anticipated to show the highest growth rate to register a CAGR of 10.2% throughout the period of forecast of 2017-2022
- Hospitals segment by end user shows higher market share of 62.1% and also grows at a higher growth rate during the forecast period. Following this segment, cardiac catheterization labs segment has secured second place with respect to market share and growth rate throughout the forecast period of 2017 to 2022
- Coronary artery disease segment by disease indication is anticipated to grow at a significantly higher growth rate to register a CAGR of 10% and also poised to hold higher market share thereby dominating the global market. This segment is also expected to gain higher BPs by the end of 2022
- Slow absorption rate segment by absorption rate is poised to register a CAGR of 10.3% throughout the period of forecast of 2017 to 2022 and also portrays dominance by reflecting a higher market share during the forecast period
Unlock exclusive insights with our expert analysts:
https://www.futuremarketinsights.com/ask-the-analyst/rep-gb-4819
The report has also profiled key leading players in the global bioabsorbable stents market, which would remain active through 2022. These include players like Lepu Medical Technology (Beijing) Co., Ltd., Becton Dickinson and Company, Boston Scientific Corporation, Kyoto Medical Planning Co., Ltd., Tepha, Inc., REVA Medical, Inc., Elixir Medical Corporation, BIOTRONIK SE & Co. KG, Amaranth Medical, Inc., and Abbott Laboratories.
Market Taxonomy Region :
- North America
- Latin America
- Europe
- Japan
- APEJ
- MEA
Product Type
- Polymeric Stents
- Metallic Stents
- Polymeric-coated Metallic Stents
End User
- Hospitals
- Cardiac Catheterization Labs
- Ambulatory Surgical Centers
Disease Indication
- Coronary Artery Disease
- Peripheral Artery Disease
Absorption Rate
- Slow Absorption Rate
- Fast Absorption Rate
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
